Literature DB >> 18480073

Rotenone-induced toxicity is mediated by Rho-GTPases in hippocampal neurons.

Monica Sanchez1, Laura Gastaldi, Monica Remedi, Alfredo Cáceres, Carlos Landa.   

Abstract

In this study, we have examined the effects of rotenone in primary cultures of hippocampal and dopaminergic neurons in order to obtain insights into the possible mechanisms underlying the neurotoxic effects of this pesticide. The results obtained indicate that a 48-h exposure to rotenone (0.1 microM) produces a complete and selective suppression of axon formation. This effect was dose dependent, not accompanied by changes in microtubule organization, and reversible after washout of the agrochemical from the tissue culture medium. Interestingly, pull-down assays revealed that rotenone decreases Cdc42 and Rac activities, whereas increasing that of Rho. In accordance with this, treatment of neuronal cultures with cytochalasin D, an actin-depolymerizing drug, or with the Rho-kinase inhibitor Y27632, or overexpression of Tiam1, a guanosine nucleotide exchange factor for Rac, reverts the inhibitory effect of rotenone on axon formation. Taken together, our data suggest that at least some of the neurotoxic effects of rotenone are associated with an inhibition of actin dynamics through modifications of Rho-GTPase activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480073     DOI: 10.1093/toxsci/kfn092

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  17 in total

1.  The neurogenic basic helix-loop-helix transcription factor NeuroD6 enhances mitochondrial biogenesis and bioenergetics to confer tolerance of neuronal PC12-NeuroD6 cells to the mitochondrial stressor rotenone.

Authors:  Kristin Kathleen Baxter; Martine Uittenbogaard; Anne Chiaramello
Journal:  Exp Cell Res       Date:  2012-07-16       Impact factor: 3.905

2.  Rotenone exerts developmental neurotoxicity in a human brain spheroid model.

Authors:  David Pamies; Katharina Block; Pierre Lau; Laura Gribaldo; Carlos A Pardo; Paula Barreras; Lena Smirnova; Daphne Wiersma; Liang Zhao; Georgina Harris; Thomas Hartung; Helena T Hogberg
Journal:  Toxicol Appl Pharmacol       Date:  2018-02-08       Impact factor: 4.219

3.  Mitochondrial Dynamics in Retinal Ganglion Cell Axon Regeneration and Growth Cone Guidance.

Authors:  Kira L Lathrop; Michael B Steketee
Journal:  J Ocul Biol       Date:  2013-09-21

4.  Evidence for the involvement of Lfc and Tctex-1 in axon formation.

Authors:  Cecilia Conde; Cristina Arias; Maria Robin; Aiqun Li; Masaki Saito; Jen-Zen Chuang; Angus C Nairn; Ching-Hwa Sung; Alfredo Cáceres
Journal:  J Neurosci       Date:  2010-05-12       Impact factor: 6.167

5.  DJ-1 knock-down impairs astrocyte mitochondrial function.

Authors:  N J Larsen; G Ambrosi; S J Mullett; S B Berman; D A Hinkle
Journal:  Neuroscience       Date:  2011-08-16       Impact factor: 3.590

6.  DJ-1 deficiency in astrocytes selectively enhances mitochondrial Complex I inhibitor-induced neurotoxicity.

Authors:  Steven J Mullett; David A Hinkle
Journal:  J Neurochem       Date:  2011-01-28       Impact factor: 5.372

7.  Behavioural effects of basal ganglia rho-kinase inhibition in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.

Authors:  Salim Yalcin Inan; Burak Cem Soner; Ayse Saide Sahin
Journal:  Metab Brain Dis       Date:  2016-03-21       Impact factor: 3.584

8.  Stem Cell-Derived Immature Human Dorsal Root Ganglia Neurons to Identify Peripheral Neurotoxicants.

Authors:  Lisa Hoelting; Stefanie Klima; Christiaan Karreman; Marianna Grinberg; Johannes Meisig; Margit Henry; Tamara Rotshteyn; Jörg Rahnenführer; Nils Blüthgen; Agapios Sachinidis; Tanja Waldmann; Marcel Leist
Journal:  Stem Cells Transl Med       Date:  2016-03-01       Impact factor: 6.940

Review 9.  Tumour metabolism and its unique properties in prostate adenocarcinoma.

Authors:  David A Bader; Sean E McGuire
Journal:  Nat Rev Urol       Date:  2020-02-28       Impact factor: 14.432

10.  Synchronous effects of targeted mitochondrial complex I inhibitors on tumor and immune cells abrogate melanoma progression.

Authors:  Mahmoud AbuEid; Donna M McAllister; Laura McOlash; Megan Cleland Harwig; Gang Cheng; Donovan Drouillard; Kathleen A Boyle; Micael Hardy; Jacek Zielonka; Bryon D Johnson; R Blake Hill; Balaraman Kalyanaraman; Michael B Dwinell
Journal:  iScience       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.